Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber. It also provides specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous chemical products
Sub-IndustryCommodity Chemicals
SectorBasic Materials
Phone617-345-0100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.34 billion
Profitability
Miscellaneous
Employees4,500
Next Earnings Date2/3/2020 (Confirmed)
OptionableOptionable
Cabot (NYSE:CBT) Frequently Asked Questions
What is Cabot's stock symbol?
Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."
How often does Cabot pay dividends? What is the dividend yield for Cabot?
Cabot declared a quarterly dividend on Friday, January 10th. Investors of record on Friday, February 28th will be given a dividend of $0.35 per share on Friday, March 13th. This represents a $1.40 dividend on an annualized basis and a yield of 3.13%. The ex-dividend date of this dividend is Thursday, February 27th. View Cabot's Dividend History.
How will Cabot's stock buyback program work?
Cabot declared that its board has initiated a stock repurchase plan on Monday, July 16th 2018, which authorizes the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 10.3% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's board of directors believes its stock is undervalued.
How were Cabot's earnings last quarter?
Cabot Corp (NYSE:CBT) posted its earnings results on Monday, November, 4th. The specialty chemicals company reported $1.05 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $1.11 by $0.06. The specialty chemicals company had revenue of $827 million for the quarter, compared to the consensus estimate of $849.44 million. Cabot had a net margin of 4.70% and a return on equity of 19.06%. The company's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.00 EPS. View Cabot's Earnings History.
When is Cabot's next earnings date?
How can I listen to Cabot's earnings call?
Cabot will be holding an earnings conference call on Monday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Cabot issued on next quarter's earnings?
Cabot issued an update on its FY20 earnings guidance on Monday, November, 4th. The company provided earnings per share (EPS) guidance of $3.60-4.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.30.
What price target have analysts set for CBT?
5 brokerages have issued 1 year price targets for Cabot's shares. Their forecasts range from $41.00 to $45.00. On average, they expect Cabot's share price to reach $44.20 in the next twelve months. This suggests that the stock has a possible downside of 1.3%. View Analyst Price Targets for Cabot.
What is the consensus analysts' recommendation for Cabot?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cabot.
Has Cabot been receiving favorable news coverage?
Media headlines about CBT stock have been trending somewhat positive on Friday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Cabot earned a coverage optimism score of 0.7 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Cabot.
Are investors shorting Cabot?
Cabot saw a decline in short interest during the month of December. As of December 31st, there was short interest totalling 799,600 shares, a decline of 11.6% from the December 15th total of 904,300 shares. Based on an average daily trading volume, of 274,200 shares, the short-interest ratio is presently 2.9 days. Approximately 1.4% of the shares of the company are short sold. View Cabot's Current Options Chain.
Who are some of Cabot's key competitors?
What other stocks do shareholders of Cabot own?
Who are Cabot's key executives?
Cabot's management team includes the folowing people:
- Mr. Sean D. Keohane, Pres, CEO & Director (Age 52)
- Ms. Erica McLaughlin, Sr. VP & CFO (Age 43)
- Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 57)
- Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 49)
- Mr. Patrick M. Prevost, Advisor & Director (Age 64)
Who are Cabot's major shareholders?
Cabot's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Cabot Wellington LLC (0.36%), Wedge Capital Management L L P NC (0.33%), Zeke Capital Advisors LLC (0.07%), Biltmore Wealth Management LLC (0.02%), State of Alaska Department of Revenue (0.02%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Cabot stock include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot.
Which institutional investors are selling Cabot stock?
CBT stock was sold by a variety of institutional investors in the last quarter, including Cabot Wellington LLC, Nisa Investment Advisors LLC, Wedge Capital Management L L P NC, State of Alaska Department of Revenue and Biltmore Wealth Management LLC. View Insider Buying and Selling for Cabot.
Which institutional investors are buying Cabot stock?
How do I buy shares of Cabot?
Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cabot's stock price today?
One share of CBT stock can currently be purchased for approximately $44.80.
How big of a company is Cabot?
Cabot has a market capitalization of $2.55 billion and generates $3.34 billion in revenue each year. The specialty chemicals company earns $157 million in net income (profit) each year or $3.91 on an earnings per share basis. Cabot employs 4,500 workers across the globe.View Additional Information About Cabot.
What is Cabot's official website?
How can I contact Cabot?
Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]
MarketBeat Community Rating for Cabot (NYSE CBT)
MarketBeat's community ratings are surveys of what our community members think about Cabot and other stocks. Vote "Outperform" if you believe CBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
